News coverage originally published on MDAtl.com.
CartiNova, an advanced regenerative medicine platform located in Buckhead, has launched and is offering minimally invasive, in-office knee and spine procedures as an alternative to traditional orthopedic surgery.
Founded by regenerative orthopedics physician Dr. Trevor Turner, CartiNova integrates FDA-cleared fractional laser technology, regenerative biologics and data-driven movement analytics to support mobility, performance and long-term joint health without surgery or extended recovery.
“Too many patients are told their only options are surgery or pain management,” said Turner, MD, RMSK, founder of CartiNova. “CartiNova was built to change that narrative by offering precise, image-guided treatments that address the health of the tissue itself, not just the symptoms.”
CartiNova’s minimally invasive procedures are performed under local anesthesia and are tailored for individuals seeking alternatives to joint replacement, spinal surgery, or extended rehabilitation. The practice treats cartilage lesions, knee degeneration, and lumbar disc disease with a personalized, closed-loop care model.
At the core of CartiNova’s approach is Regenelase fractional laser technology, which delivers microthermal stimulation via a needle-based system to targeted cartilage or disc tissue. This technology is designed to enhance the body’s natural healing response while avoiding the trauma of open surgery.
In addition to laser therapy, CartiNova offers optional regenerative biologic treatments, such as platelet-rich plasma, bone marrow concentrate, and microfragmented adipose tissue. These therapies are paired with advanced imaging, precision diagnostics, and movement-based recovery analytics to guide treatment and improve outcomes.
In partnership with Forever Labs, the first ISO-certified biobank in the U.S., CartiNova offers the option to preserve a portion of harvested biologic material, allowing qualified patients to retain access to their own cells for potential future physician-directed therapies as regenerative medicine continues to evolve.
“Our goal is to make advanced regenerative care, once reserved for elite athletes, accessible to active adults who want to move better, heal efficiently, and avoid unnecessary surgery,” Turner said.
CartiNova also integrates diagnostics and performance technology to personalize care. Advanced movement and strength analysis, force-plate testing, and range-of-motion metrics guide rehabilitation and track measurable progress throughout recovery.
“Regenerative joint and spine care should be precise, minimally invasive and data-informed,” Turner said. “By unifying laser technology, biologic medicine and performance-driven rehabilitation, CartiNova offers a comprehensive approach to long-term joint preservation.”
Turner attended UT Southwestern Medical School, completed a General Surgery internship at UCSF, and finished his Physical Medicine & Rehabilitation residency at the University of Alabama at Birmingham, where he participated in ACL injury research with the American Sports Medicine Institute.
He also holds advanced fitness and performance certifications through EXOS, the National Strength and Conditioning Association (NSCA), and CrossFit, bridging elite athletic training with clinical medicine. In addition, Dr. Turner completed a Precision Medicine Fellowship with Wild Health, further deepening his expertise in data-driven, personalized care.
Dr. Turner then spent four years training under Dr. James Andrews at the Andrews Orthopedics & Sports Medicine Institute, caring for professional and collegiate athletes, Olympic competitors, military special operations personnel, and active adults seeking musculoskeletal care.
